InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Abbott Laboratories

ABT Clue Score62
United States Fiscal year ends December CIK 0000001800
$99.60 +1.13% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $99.60 −14.78% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue20.85Operating income3.03Net income1.40EPS, diluted0.94Fiscal year 2017Revenue27.39 +31.3%Operating income1.56Net income0.48 −65.9%EPS, diluted0.27 −71.3%Fiscal year 2018Revenue30.58 +11.6%Operating income3.65Net income2.37 +396.4%EPS, diluted1.33 +392.6%Fiscal year 2019Revenue31.90 +4.3%Operating income4.53Net income3.69 +55.7%EPS, diluted2.06 +54.9%Fiscal year 2020Revenue34.61 +8.5%Operating income5.36Net income4.50 +21.9%EPS, diluted2.50 +21.4%Fiscal year 2021Revenue43.08 +24.5%Operating income8.43Net income7.07 +57.3%EPS, diluted3.94 +57.6%Fiscal year 2022Revenue43.65 +1.3%Operating income8.36Net income6.93 −2.0%EPS, diluted3.91 −0.8%Fiscal year 2023Revenue40.11 −8.1%Operating income6.48Net income5.72 −17.5%EPS, diluted3.26 −16.6%Fiscal year 2024Revenue41.95 +4.6%Operating income6.83Net income13.40 +134.2%EPS, diluted7.64 +134.4%Fiscal year 2025Revenue44.33 +5.7%Operating income8.05Net income6.52 −51.3%EPS, diluted3.72 −51.3%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 20.85 27.39 30.58 31.90 34.61 43.08 43.65 40.11 41.95 44.33
Growth +31.3% +11.6% +4.3% +8.5% +24.5% +1.3% −8.1% +4.6% +5.7%
Operating income 3.03 1.56 3.65 4.53 5.36 8.43 8.36 6.48 6.83 8.05
Net income 1.40 0.48 2.37 3.69 4.50 7.07 6.93 5.72 13.40 6.52
Growth −65.9% +396.4% +55.7% +21.9% +57.3% −2.0% −17.5% +134.2% −51.3%
EPS, diluted 0.94 0.27 1.33 2.06 2.50 3.94 3.91 3.26 7.64 3.72
Growth −71.3% +392.6% +54.9% +21.4% +57.6% −0.8% −16.6% +134.4% −51.3%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin14.5%Net margin6.7%Free cash flow margin10.0%Fiscal year 2017Operating margin5.7%Net margin1.7%Free cash flow margin16.2%Fiscal year 2018Operating margin11.9%Net margin7.7%Free cash flow margin16.0%Fiscal year 2019Operating margin14.2%Net margin11.6%Free cash flow margin14.1%Fiscal year 2020Operating margin15.5%Net margin13.0%Free cash flow margin16.5%Fiscal year 2021Operating margin19.6%Net margin16.4%Free cash flow margin20.1%Fiscal year 2022Operating margin19.2%Net margin15.9%Free cash flow margin17.9%Fiscal year 2023Operating margin16.2%Net margin14.3%Free cash flow margin12.6%Fiscal year 2024Operating margin16.3%Net margin31.9%Free cash flow margin15.1%Fiscal year 2025Operating margin18.2%Net margin14.7%Free cash flow margin16.7%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin 14.5% 5.7% 11.9% 14.2% 15.5% 19.6% 19.2% 16.2% 16.3% 18.2%
Net margin 6.7% 1.7% 7.7% 11.6% 13.0% 16.4% 15.9% 14.3% 31.9% 14.7%
Free cash flow margin 10.0% 16.2% 16.0% 14.1% 16.5% 20.1% 17.9% 12.6% 15.1% 16.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow3.20Capital expenditure−1.12Free cash flow2.08Buybacks−0.52Dividends paid−1.54Fiscal year 2017Operating cash flow5.57Capital expenditure−1.14Free cash flow4.44 +113.0%Buybacks−0.12Dividends paid−1.85Fiscal year 2018Operating cash flow6.30Capital expenditure−1.39Free cash flow4.91 +10.6%Buybacks−0.24Dividends paid−1.97Fiscal year 2019Operating cash flow6.14Capital expenditure−1.64Free cash flow4.50 −8.3%Buybacks−0.72Dividends paid−2.27Fiscal year 2020Operating cash flow7.90Capital expenditure−2.18Free cash flow5.72 +27.3%Buybacks−0.40Dividends paid−2.56Fiscal year 2021Operating cash flow10.53Capital expenditure−1.89Free cash flow8.65 +51.1%Buybacks−2.30Dividends paid−3.20Fiscal year 2022Operating cash flow9.58Capital expenditure−1.78Free cash flow7.80 −9.8%Buybacks−3.80Dividends paid−3.31Fiscal year 2023Operating cash flow7.26Capital expenditure−2.20Free cash flow5.06 −35.2%Buybacks−1.23Dividends paid−3.56Fiscal year 2024Operating cash flow8.56Capital expenditure−2.21Free cash flow6.35 +25.5%Buybacks−1.30Dividends paid−3.84Fiscal year 2025Operating cash flow9.57Capital expenditure−2.17Free cash flow7.40 +16.4%Buybacks−0.89Dividends paid−4.12
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 3.20 5.57 6.30 6.14 7.90 10.53 9.58 7.26 8.56 9.57
Capital expenditure −1.12 −1.14 −1.39 −1.64 −2.18 −1.89 −1.78 −2.20 −2.21 −2.17
Free cash flow 2.08 4.44 4.91 4.50 5.72 8.65 7.80 5.06 6.35 7.40
Growth +113.0% +10.6% −8.3% +27.3% +51.1% −9.8% −35.2% +25.5% +16.4%
Buybacks −0.52 −0.12 −0.24 −0.72 −0.40 −2.30 −3.80 −1.23 −1.30 −0.89
Dividends paid −1.54 −1.85 −1.97 −2.27 −2.56 −3.20 −3.31 −3.56 −3.84 −4.12

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash18.62Total debt20.68Net cash (debt)−2.06Shareholders’ equity20.54Debt to equity1.01Fiscal year 2017Cash9.41Total debt27.72Net cash (debt)−18.31Shareholders’ equity30.90Debt to equity0.90Fiscal year 2018Cash3.84Total debt19.37Net cash (debt)−15.52Shareholders’ equity30.52Debt to equity0.63Fiscal year 2019Cash3.86Total debt17.94Net cash (debt)−14.08Shareholders’ equity31.09Debt to equity0.58Fiscal year 2020Cash6.84Total debt18.53Net cash (debt)−11.70Shareholders’ equity32.78Debt to equity0.57Fiscal year 2021Cash9.80Total debt18.05Net cash (debt)−8.25Shareholders’ equity35.80Debt to equity0.50Fiscal year 2022Cash9.88Total debt16.77Net cash (debt)−6.89Shareholders’ equity36.69Debt to equity0.46Fiscal year 2023Cash6.90Total debt14.68Net cash (debt)−7.78Shareholders’ equity38.60Debt to equity0.38Fiscal year 2024Cash7.62Total debt14.13Net cash (debt)−6.51Shareholders’ equity47.66Debt to equity0.30Fiscal year 2025Cash8.52Total debt12.93Net cash (debt)−4.41Shareholders’ equity52.13Debt to equity0.25
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 18.62 9.41 3.84 3.86 6.84 9.80 9.88 6.90 7.62 8.52
Total debt 20.68 27.72 19.37 17.94 18.53 18.05 16.77 14.68 14.13 12.93
Net cash (debt) −2.06 −18.31 −15.52 −14.08 −11.70 −8.25 −6.89 −7.78 −6.51 −4.41
Shareholders’ equity 20.54 30.90 30.52 31.09 32.78 35.80 36.69 38.60 47.66 52.13
Debt to equity 1.01 0.90 0.63 0.58 0.57 0.50 0.46 0.38 0.30 0.25

In billions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In billions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
20.85 27.39 30.58 31.90 34.61 43.08 43.65 40.11 41.95 44.33
Growth +31.3% +11.6% +4.3% +8.5% +24.5% +1.3% −8.1% +4.6% +5.7%
9.09 12.41 12.71 13.23 15.00 18.54 19.14 17.98 18.71 19.32
n/a 2.26 2.30 2.44 2.42 2.74 2.89 2.74 2.84 2.94
6.74 9.18 9.74 9.77 9.70 11.32 11.25 10.95 11.70 12.33
3.03 1.56 3.65 4.53 5.36 8.43 8.36 6.48 6.83 8.05
Growth −48.3% +133.4% +24.2% +18.2% +57.3% −0.7% −22.5% +5.4% +18.0%
1.41 2.23 2.87 4.08 4.97 8.21 8.31 6.66 7.01 8.47
0.35 1.88 0.54 0.39 0.50 1.14 1.37 0.94 −6.39 1.94
1.40 0.48 2.37 3.69 4.50 7.07 6.93 5.72 13.40 6.52
Growth −65.9% +396.4% +55.7% +21.9% +57.3% −2.0% −17.5% +134.2% −51.3%
Per share
0.94 0.27 1.34 2.07 2.52 3.97 3.94 3.28 7.67 3.73
0.94 0.27 1.33 2.06 2.50 3.94 3.91 3.26 7.64 3.72
Growth −71.3% +392.6% +54.9% +21.4% +57.6% −0.8% −16.6% +134.4% −51.3%
1,477 1,740 1,758 1,768 1,773 1,775 1,753 1,740 1,740 1,741
1,483 1,749 1,770 1,781 1,786 1,789 1,764 1,749 1,748 1,748
Growth +17.9% +1.2% +0.6% +0.3% +0.2% −1.4% −0.9% −0.1% +0.0%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 5.1% a year over five years, and earnings per share grew 8.3% a year.
  • The diluted share count fell 2.1% in five years, so buybacks did some of the work per share.
  • Operating margin is up 2.7 points on five years ago, at 18.2%.
  • Profitable in every one of the 10 years on file.